Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade
暂无分享,去创建一个
P. E. Van den Steen | G. Opdenakker | J. Vandooren | Philippe E Van den Steen | Ghislain Opdenakker | Jennifer Vandooren
[1] J. Challis,et al. Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes. , 2005, The Journal of clinical endocrinology and metabolism.
[2] Vandana Iyer,et al. α3β1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expression , 2005, Journal of Cell Science.
[3] Z. Werb,et al. Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. , 2007, Cancer research.
[4] B. Zabel,et al. Mutations in MMP9 and MMP13 determine the mode of inheritance and the clinical spectrum of metaphyseal anadysplasia. , 2009, American journal of human genetics.
[5] S. Ball,et al. Simvastatin inhibits TNFα-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms , 2007 .
[6] N. Bresolin,et al. Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts , 2003, Science.
[7] G. Opdenakker,et al. Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. , 1991, Lymphokine and cytokine research.
[8] R. Khokha,et al. Clipping, shedding and RIPping keep immunity on cue. , 2008, Trends in immunology.
[9] P. Wang,et al. Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[10] S. Rafii,et al. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9–mediated progenitor cell mobilization , 2005, The Journal of experimental medicine.
[11] G. Verleden,et al. Azithromycin decreases MMP-9 expression in the airways of lung transplant recipients. , 2011, Transplant immunology.
[12] J. Enghild,et al. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. , 1992, The Journal of biological chemistry.
[13] Oliver Schilling,et al. Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites , 2008, Nature Biotechnology.
[14] L. Deangelis,et al. YKL‐40 and MMP‐9 as serum markers for patients with primary central nervous system lymphoma , 2011, Annals of neurology.
[15] H. Hsieh,et al. Calmodulin kinase II-dependent transactivation of PDGF receptors mediates astrocytic MMP-9 expression and cell motility induced by lipoteichoic acid , 2010, Journal of Neuroinflammation.
[16] P. Mcgeer,et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. , 2001, The American journal of pathology.
[17] Y. St-Pierre,et al. Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. , 2002, Biochemical and biophysical research communications.
[18] D. Hanahan,et al. MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.
[19] P. E. Van den Steen,et al. Targeting matrix metalloproteinases in acute inflammatory shock syndromes. , 2012, Combinatorial chemistry & high throughput screening.
[20] Li Yan,et al. The High Molecular Weight Urinary Matrix Metalloproteinase (MMP) Activity Is a Complex of Gelatinase B/MMP-9 and Neutrophil Gelatinase-associated Lipocalin (NGAL) , 2001, The Journal of Biological Chemistry.
[21] P. E. Van den Steen,et al. Insufficiently Defined Genetic Background Confounds Phenotypes in Transgenic Studies As Exemplified by Malaria Infection in Tlr9 Knockout Mice , 2011, PloS one.
[22] P. E. Van den Steen,et al. A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains. , 2007, Biochimica et biophysica acta.
[23] Ping Pei,et al. Reduced nonprotein thiols inhibit activation and function of MMP-9: implications for chemoprevention. , 2006, Free radical biology & medicine.
[24] Takehiro Suzuki,et al. Protein disulfide isomerase-mediated disulfide bonds regulate the gelatinolytic activity and secretion of matrix metalloproteinase-9. , 2012, Experimental cell research.
[25] C. Gondi,et al. Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non–small cell lung cancer cells , 2005, Molecular Cancer Therapeutics.
[26] S. Takai,et al. Molecular mechanism of imidapril for cardiovascular protection via inhibition of MMP-9. , 2007, Journal of molecular and cellular cardiology.
[27] C. Jackson,et al. Autocrine actions of matrix metalloproteinase (MMP)-2 counter the effects of MMP-9 to promote survival and prevent terminal differentiation of cultured human keratinocytes. , 2008, The Journal of investigative dermatology.
[28] Benedikt M Kessler,et al. Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1. , 2010, Cancer research.
[29] G. Thomas,et al. The Integrin Cytoplasmic-tail Motif EKQKVDLSTDC Is Sufficient to Promote Tumor Cell Invasion Mediated by Matrix Metalloproteinase (MMP)-2 or MMP-9* , 2004, Journal of Biological Chemistry.
[30] B. Freeman,et al. Electrophilic Fatty Acids Regulate Matrix Metalloproteinase Activity and Expression* , 2011, The Journal of Biological Chemistry.
[31] P. Herdewijn,et al. Gelatin degradation assay reveals MMP-9 inhibitors and function of O-glycosylated domain. , 2011, World journal of biological chemistry.
[32] C. Overall,et al. Multiplex N-terminome Analysis of MMP-2 and MMP-9 Substrate Degradomes by iTRAQ-TAILS Quantitative Proteomics* , 2010, Molecular & Cellular Proteomics.
[33] C. Dabrosin,et al. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo. , 2008, Cancer research.
[34] M. Bar‐eli,et al. Loss of AP-2α results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo , 2007, Oncogene.
[35] J. Madri,et al. MMP‐2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP‐9 expression and activity , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] Y. St-Pierre,et al. A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression. , 2005, Cancer research.
[37] Ziad J. Sahab,et al. Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. , 2008, Current pharmaceutical biotechnology.
[38] T. Pourmotabbed,et al. Identification of structural elements important for matrix metalloproteinase type V collagenolytic activity as revealed by chimeric enzymes. Role of fibronectin-like domain and active site of gelatinase B. , 2000, The Journal of biological chemistry.
[39] P. E. Van den Steen,et al. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. , 2000, Blood.
[40] A. Dannenberg,et al. Matrix Metalloproteinase (MMP)-1 and MMP-3 Induce Macrophage MMP-9: Evidence for the Role of TNF-α and Cyclooxygenase-21 , 2009, The Journal of Immunology.
[41] G. Opdenakker,et al. Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis , 2003, The Lancet Neurology.
[42] Shu Meng,et al. Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages. , 2011, International journal of cardiology.
[43] S. Tyagi,et al. Gelatinase B(MMP-9) an apoptotic factor in diabetic transgenic mice , 2003, Diabetologia.
[44] I. Harvima. Induction of matrix metalloproteinase-9 in keratinocytes by histamine. , 2008, The Journal of investigative dermatology.
[45] H. Guo,et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. , 1995, Cancer research.
[46] M. Yılmaz,et al. Exhaled breath condensate MMP‐9 levels in children with bronchiectasis , 2009, Pediatric pulmonology.
[47] G. Kouraklis,et al. Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion , 2002, Oncogene.
[48] D. Radisky,et al. Respect Thy Neighbor! , 2004, Science.
[49] L. Bhatt,et al. Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathy , 2010, Neurological Sciences.
[50] J. Delaissé,et al. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. , 1995, Journal of cell science.
[51] D. Moazed. Small RNAs in transcriptional gene silencing and genome defence , 2009, Nature.
[52] Jiankun Cui,et al. S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death , 2002, Science.
[53] Yang Shi,et al. Ineffectiveness of Histone Deacetylase Inhibitors to Induce Apoptosis Involves the Transcriptional Activation of NF-κB through the Akt Pathway* , 2003, Journal of Biological Chemistry.
[54] Y. Nishimura,et al. Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[55] M. Sales,et al. Immunoglobulin G from Breast Cancer Patients Regulates MCF-7 Cells Migration and MMP-9 Activity by Stimulating Muscarinic Acetylcholine Receptors , 2012, Journal of Clinical Immunology.
[56] E. Raines,et al. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. , 2005, The Journal of clinical investigation.
[57] Y. Itoh,et al. MT1-MMP: an enzyme with multidimensional regulation. , 2004, Trends in biochemical sciences.
[58] C. Libert,et al. Matrix Metalloproteinases as Drug Targets in Infections Caused by Gram-Negative Bacteria and in Septic Shock , 2009, Clinical Microbiology Reviews.
[59] S. Ball,et al. Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms. , 2007, Journal of molecular and cellular cardiology.
[60] K. Naka,et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. , 1992, The Journal of biological chemistry.
[61] R. Dwek,et al. Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin. , 1999, Biochemistry.
[62] P. E. Van den Steen,et al. Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock. , 2005, Biochemical pharmacology.
[63] M. Haber,et al. Enhancing the anti-angiogenic action of histone deacetylase inhibitors , 2007, Molecular Cancer.
[64] A. Henney,et al. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor. , 2002, Journal of molecular biology.
[65] Carlos López-Otín,et al. Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.
[66] L. Young,et al. Targeting an MMP-9-activated prodrug to multiple myeloma-diseased bone marrow: a proof of principle in the 5T33MM mouse model , 2005, Leukemia.
[67] J. Quigley,et al. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis , 2007, Proceedings of the National Academy of Sciences.
[68] Tetsuo Himi,et al. Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non‐Hodgkin lymphoma , 2004, Cancer.
[69] M. Bernardo,et al. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. , 2003, Biochemical and biophysical research communications.
[70] Christopher M. Overall,et al. Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.
[71] Jae-Hyun Park,et al. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. , 2012, Cancer cell.
[72] G. Opdenakker,et al. In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[73] H. Birkedal‐Hansen,et al. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[74] R. Béliveau,et al. Ischemia injury alters endothelial cell properties of kidney cortex: stimulation of MMP-9. , 2005, Experimental cell research.
[75] P. E. Van den Steen,et al. Simulation of evolution-selected propeptide by high-throughput selection of a peptidomimetic inhibitor on a capillary DNA sequencer platform. , 2005, Analytical chemistry.
[76] Yvonne Tay,et al. A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes , 2006, Cell.
[77] H. Hieronymus,et al. A systems view of mRNP biology. , 2004, Genes & development.
[78] Robert P. Hammer,et al. Selective Modulation of Matrix Metalloproteinase 9 (MMP-9) Functions via Exosite Inhibition* , 2008, Journal of Biological Chemistry.
[79] S. Yamashita,et al. Expression of the Axl receptor tyrosine kinase in human thyroid carcinoma. , 1999, Thyroid : official journal of the American Thyroid Association.
[80] W. Sakr,et al. Design and characterization of a metalloproteinase inhibitor-tethered resin for the detection of active MMPs in biological samples. , 2006, Chemistry & biology.
[81] Hou-qi Liu,et al. SHP-2 promoting migration and metastasis of MCF-7 with loss of E-cadherin, dephosphorylation of FAK and secretion of MMP-9 induced by IL-1 βin vivo andin vitro , 2004, Breast Cancer Research and Treatment.
[82] G. Kim,et al. The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus , 2009, Neurobiology of Disease.
[83] C. Kahn,et al. Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis , 2002, Science.
[84] M. Fini,et al. Cytokines and signaling pathways regulating matrix metalloproteinase‐9 (MMP‐9) expression in corneal epithelial cells , 2009, Journal of cellular physiology.
[85] G. Murphy. The ADAMs: signalling scissors in the tumour microenvironment , 2008, Nature Reviews Cancer.
[86] D. Sorbi,et al. Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases. , 1993, Kidney international.
[87] Qiang Zhou,et al. Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately , 2008, Proceedings of the National Academy of Sciences.
[88] Giulio Cossu,et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs , 2006, Nature.
[89] M. Goggins,et al. Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. , 2003, Journal of the National Cancer Institute.
[90] A. Ubbelohde,et al. Cataphoresis of Crystal Nuclei , 1954, Nature.
[91] Lorraine Lau,et al. MMPs in the central nervous system: where the good guys go bad. , 2008, Seminars in cell & developmental biology.
[92] O. Arancio,et al. 5-HT₄ receptor stimulation leads to soluble AβPPα production through MMP-9 upregulation. , 2012, Journal of Alzheimer's disease : JAD.
[93] S. Lemeshow,et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. , 2006, Cancer research.
[94] Wesley R. Legant,et al. Diffusion of MMPs on the Surface of Collagen Fibrils: The Mobile Cell Surface – Collagen Substratum Interface , 2011, PloS one.
[95] R. Sciot,et al. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. , 1999, The Journal of clinical investigation.
[96] C. Y. Chen,et al. AU-rich elements: characterization and importance in mRNA degradation. , 1995, Trends in biochemical sciences.
[97] X. Puente,et al. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors , 2004, Biological chemistry.
[98] D. Jeoung,et al. A Splice Variant of CD99 Increases Motility and MMP-9 Expression of Human Breast Cancer Cells through the AKT-, ERK-, and JNK-dependent AP-1 Activation Signaling Pathways* , 2006, Journal of Biological Chemistry.
[99] B. Cauwe,et al. Adenylyl cyclase-associated protein-1/CAP1 as a biological target substrate of gelatinase B/MMP-9. , 2008, Experimental cell research.
[100] P. Amouyel,et al. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. , 2002, Journal of the American College of Cardiology.
[101] S. Rafii,et al. Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis. , 2007, Experimental neurology.
[102] P. McGuire,et al. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood–retinal barrier , 2005, Laboratory Investigation.
[103] P. E. Van den Steen,et al. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post‐translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[104] S. Tang,et al. Diabetic tubulopathy: an emerging entity. , 2011, Contributions to nephrology.
[105] J. Powell,et al. Shear stress‐induced shedding of soluble intercellular adhesion molecule‐1 from saphenous vein endothelium , 2004, FEBS letters.
[106] I. Stamenkovic,et al. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.
[107] S. Slater,et al. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation. , 2009, Cardiovascular research.
[108] Hyun-Jai Cho,et al. New Mechanism of Rosiglitazone to Reduce Neointimal Hyperplasia: Activation of Glycogen Synthase Kinase-3&bgr; Followed by Inhibition of MMP-9 , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[109] P. Collin‐Osdoby,et al. Stromal Cell‐Derived Factor‐1 (SDF‐1) Recruits Osteoclast Precursors by Inducing Chemotaxis, Matrix Metalloproteinase‐9 (MMP‐9) Activity, and Collagen Transmigration , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[110] A. Clowes,et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. , 1999, Circulation research.
[111] Pedro Romero,et al. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity , 2002, Oncogene.
[112] S. Yagihashi,et al. Role of advanced glycation end products in diabetic neuropathy. , 2008, Current pharmaceutical design.
[113] P. E. Van den Steen,et al. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3. , 2008, Biochemistry.
[114] S. Ball,et al. Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. , 2004, Cardiovascular research.
[115] R. Bischoff,et al. Active metalloproteases of the A Disintegrin and Metalloprotease (ADAM) family: biological function and structure. , 2011, Journal of proteome research.
[116] C. Muller,et al. The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9 , 2004, The EMBO journal.
[117] A. Cano,et al. Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor , 2005, Journal of Cell Science.
[118] E. D. Bal de Kier Joffé,et al. Circulating 92‐kilodalton matrix metalloproteinase (MMP‐9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma , 2002, Cancer.
[119] L. Boscá,et al. Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis. , 2006, The American journal of pathology.
[120] Y. Kobayashi. Langerhans’ cells produce type IV collagenase (MMP‐9) following epicutaneous stimulation with haptens , 1997, Immunology.
[121] W. Robberecht,et al. Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis , 2005, Neuroreport.
[122] C. Soria,et al. Activation of the 92 kDa type IV collagenase by tissue kallikrein , 1993, Journal of cellular physiology.
[123] R. Kizek,et al. Matrix metalloproteinases. , 2010, Current medicinal chemistry.
[124] G. Opdenakker,et al. Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis. , 2006, Microbes and infection.
[125] Takashi Kobayashi,et al. Matrix metalloproteinase 9 expression is coordinately modulated by the KRE-M9 and 12-O-tetradecanoyl-phorbol-13-acetate responsive elements. , 2004, The Journal of investigative dermatology.
[126] G. Opdenakker,et al. Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation. , 1993, European journal of biochemistry.
[127] G. Opdenakker,et al. Gelatinase B in proliferative vitreoretinal disorders. , 1998, American journal of ophthalmology.
[128] V. Kosma,et al. Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis , 2004, Clinical Cancer Research.
[129] A. Demchuk,et al. Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice. , 2010, The American journal of pathology.
[130] M. Björklund,et al. Identification of a Negatively Charged Peptide Motif within the Catalytic Domain of Progelatinases That Mediates Binding to Leukocyte β2 Integrins* , 2003, Journal of Biological Chemistry.
[131] C. Overall,et al. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen , 1995, The Journal of Biological Chemistry.
[132] A. Eisen,et al. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. , 1989, The Journal of biological chemistry.
[133] S. Molica,et al. Increased serum levels of matrix metalloproteinase‐9 predict clinical outcome of patients with early B‐cell chronic lymphocytic leukaemia , 2003, European journal of haematology.
[134] G. Opdenakker,et al. VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. , 2012, Blood.
[135] A. Chalaris,et al. The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10 , 2012, Cellular and Molecular Life Sciences.
[136] C. Munaut,et al. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development , 1994, The Journal of cell biology.
[137] I. Behrmann,et al. The Matrix Metalloproteinase 9 (MMP-9) Hemopexin Domain Is a Novel Gelatin Binding Domain and Acts as an Antagonist* , 2002, The Journal of Biological Chemistry.
[138] A. Morgan,et al. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease , 2003, Journal of Molecular Medicine.
[139] A. Strongin,et al. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. , 1992, The Journal of biological chemistry.
[140] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[141] E. Şevketoğlu,et al. Urinary MMP-9/NGAL complex in children with acute cystitis , 2011, Pediatric Nephrology.
[142] J. Kos,et al. Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[143] M. Lindsey,et al. ACE inhibitors to block MMP-9 activity: new functions for old inhibitors. , 2007, Journal of molecular and cellular cardiology.
[144] G. Opdenakker,et al. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis , 2006, The Journal of experimental medicine.
[145] F. Mannello. Circulating 92‐kilodalton matrix metalloproteinase (MMP‐9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma , 2003, Cancer.
[146] R. Pauwels,et al. Matrix Metalloproteinase-9-Mediated Dendritic Cell Recruitment into the Airways Is a Critical Step in a Mouse Model of Asthma1 , 2003, The Journal of Immunology.
[147] S. Martínez,et al. Inhibition of Histone Deacetylase Activity in Human Endometrial Stromal Cells Promotes Extracellular Matrix Remodelling and Limits Embryo Invasion , 2012, PloS one.
[148] V. Yong,et al. Fibronectin attenuates process outgrowth in oligodendrocytes by mislocalizing MMP-9 activity , 2009, Molecular and Cellular Neuroscience.
[149] D. Bolignano,et al. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. , 2010, Cancer letters.
[150] J. Kolb,et al. Hyperforin inhibits MMP-9 secretion by B-CLL cells and microtubule formation by endothelial cells , 2006, Leukemia.
[151] P. E. Van den Steen,et al. Meprins process matrix metalloproteinase‐9 (MMP‐9)/gelatinase B and enhance the activation kinetics by MMP‐3 , 2012, FEBS letters.
[152] G. Opdenakker,et al. A novel rationale for inhibition of gelatinase B in multiple sclerosis: MMP-9 destroys αB-crystallin and generates a promiscuous T cell epitope , 2003, Journal of Neuroimmunology.
[153] J. Nyman,et al. Differential effects between the loss of MMP‐2 and MMP‐9 on structural and tissue‐level properties of bone , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[154] K. Matsumura,et al. Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan. , 2006, Biochemical and biophysical research communications.
[155] G. Opdenakker,et al. Analysis of Gelatinases in Complex Biological Fluids and Tissue Extracts , 2002, Laboratory Investigation.
[156] M. Flannery,et al. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. , 1996, Development.
[157] S. Weiss,et al. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[158] B. Aggarwal,et al. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. , 2003, Carcinogenesis.
[159] R. S. Goldstein,et al. Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo , 2009, Leukemia & lymphoma.
[160] William C. Parks,et al. MMP-9 Sheds the β2 Integrin Subunit (CD18) from Macrophages*S , 2009, Molecular & Cellular Proteomics.
[161] T. Tatusova,et al. Entrez Gene: gene-centered information at NCBI , 2006, Nucleic Acids Res..
[162] T. Salo,et al. Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis. , 2003, The Annals of thoracic surgery.
[163] Hiroshi Sato,et al. Homophilic complex formation of MT1‐MMP facilitates proMMP‐2 activation on the cell surface and promotes tumor cell invasion , 2001, The EMBO journal.
[164] B. Cauwe,et al. Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases , 2010, Critical reviews in biochemistry and molecular biology.
[165] C. Manthey,et al. Matrix metalloproteinase-9 inhibition reduces inflammation and improves motility in murine models of postoperative ileus. , 2011, Gastroenterology.
[166] H. Lijnen. Plasmin and Matrix Metalloproteinases in Vascular Remodeling , 2001, Thrombosis and Haemostasis.
[167] R. Mrowka,et al. Role of nucleolin in posttranscriptional control of MMP-9 expression. , 2005, Biochimica et biophysica acta.
[168] S. Canevari,et al. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro , 1999, Clinical & Experimental Metastasis.
[169] P. Libby,et al. Generation of Biologically Active IL-1β by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1β Processing , 1998, The Journal of Immunology.
[170] M. Björklund,et al. Peptide Inhibition of Catalytic and Noncatalytic Activities of Matrix Metalloproteinase-9 Blocks Tumor Cell Migration and Invasion* , 2004, Journal of Biological Chemistry.
[171] J. Hoover-Plow,et al. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. , 2008, The Journal of clinical investigation.
[172] F. Dallocchio,et al. Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms. , 2012, Journal of biochemistry.
[173] C. Peschel,et al. Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells , 2004, Leukemia.
[174] Li Yan,et al. Dynamic changes in matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 levels during wound healing in diabetic rats. , 2009, Journal of the American Podiatric Medical Association.
[175] Robert J. Hinchliffe,et al. Pathophysiology and epidemiology of abdominal aortic aneurysms , 2011, Nature Reviews Cardiology.
[176] D. Boyd,et al. KiSS-1 Represses 92-kDa Type IV Collagenase Expression by Down-regulating NF-κB Binding to the Promoter as a Consequence of IκBα-induced Block of p65/p50 Nuclear Translocation* , 2001, The Journal of Biological Chemistry.
[177] Raymond A. Dwek,et al. Glycobiology: Toward Understanding the Function of Sugars. , 1996, Chemical reviews.
[178] S. Apte. A Disintegrin-like and Metalloprotease (Reprolysin-type) with Thrombospondin Type 1 Motif (ADAMTS) Superfamily: Functions and Mechanisms* , 2009, The Journal of Biological Chemistry.
[179] O. Wiklund,et al. Release of protein as well as activity of MMP‐9 from unstable atherosclerotic plaques during percutaneous coronary intervention , 2007, Journal of internal medicine.
[180] P. E. Van den Steen,et al. Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulin , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[181] S. Nourshargh,et al. Matrix Metalloproteinase-9 Deficiency Results in Enhanced Allergen-Induced Airway Inflammation1 , 2004, The Journal of Immunology.
[182] L. Elijovich,et al. Current and Future Use of Intravenous Thrombolysis for Acute Ischemic Stroke , 2010, Current atherosclerosis reports.
[183] L. Kotra,et al. Matrix metalloproteinases: structures, evolution, and diversification , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[184] T. Pourmotabbed. Relation between Substrate Specificity and Domain Structure of 92‐kDa Type IV Collagenase a , 1994, Annals of the New York Academy of Sciences.
[185] Y. Nishimura,et al. Induction of MMP-9 in normal human bronchial epithelial cells by TNF-α via NF-κB-mediated pathway , 2001 .
[186] Ke Lin,et al. The role of matrix metalloproteinase 9 in the pathogenesis of chronic lymphocytic leukaemia , 2004, British journal of haematology.
[187] S. O. Kolset,et al. Calcium-induced activation and truncation of promatrix metalloproteinase-9 linked to the core protein of chondroitin sulfate proteoglycans. , 2003, European journal of biochemistry.
[188] Atsushi Shoji,et al. Real-time monitoring of matrix metalloproteinase-9 collagenolytic activity with a surface plasmon resonance biosensor. , 2011, Analytical biochemistry.
[189] G. Kaushal,et al. Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains. , 2011, Biochimica et biophysica acta.
[190] L. Uhlin‐Hansen,et al. Interaction of Pro-matrix Metalloproteinase-9/Proteoglycan Heteromer with Gelatin and Collagen* , 2008, Journal of Biological Chemistry.
[191] P. Doevendans,et al. MiR-155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP-16 , 2012, Journal of cellular and molecular medicine.
[192] J. Seltzer,et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.
[193] A. Clowes,et al. MMP-9 regulates both positively and negatively collagen gel contraction: a nonproteolytic function of MMP-9. , 2005, Cardiovascular research.
[194] A. Krüger,et al. Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. , 2007, Cancer research.
[195] M. Fini,et al. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology , 2002, Progress in Retinal and Eye Research.
[196] S. Fukuda,et al. Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GROβ/CXCL2 and GROβT /CXCL2Δ4 , 2004 .
[197] P. Bornstein,et al. The Low Density Lipoprotein Receptor-related Protein Modulates Levels of Matrix Metalloproteinase 9 (MMP-9) by Mediating Its Cellular Catabolism* , 2001, The Journal of Biological Chemistry.
[198] J. Fata,et al. Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line , 1998, Oncogene.
[199] D. Boyd,et al. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation. , 2001, The Journal of biological chemistry.
[200] T. Major,et al. Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Is Induced Upon Monocyte Differentiation and Is Expressed in Human Atheroma , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[201] A. Strongin,et al. Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase. , 1992, The Journal of biological chemistry.
[202] J. O'Connell,et al. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. , 1994, The Journal of biological chemistry.
[203] R. L. Brown,et al. Matrix metalloproteinase-9 and -2 enhance the ligand sensitivity of photoreceptor cyclic nucleotide-gated channels , 2012, Channels.
[204] Z. Werb,et al. Gelatinase B–deficient Mice Are Resistant to Experimental Bullous Pemphigoid , 1998, The Journal of experimental medicine.
[205] Hongwei Jin,et al. Cortical spreading depression activates and upregulates MMP-9. , 2004, The Journal of clinical investigation.
[206] Christopher M. Overall,et al. Degradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancer , 2006, Cancer and Metastasis Reviews.
[207] T. Betsuyaku,et al. The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. , 2011, American journal of respiratory and critical care medicine.
[208] R. Muschel,et al. On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. , 2012, Critical reviews in oncology/hematology.
[209] Qi-Zhuang Ye,et al. The Structural Basis for the Elastolytic Activity of the 92-kDa and 72-kDa Gelatinases , 1996, The Journal of Biological Chemistry.
[210] H. Saito,et al. Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate. , 2004, International journal of oncology.
[211] David B. Alexander,et al. The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis , 2001, Cell.
[212] S. O. Kolset,et al. Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. , 2000, Journal of molecular biology.
[213] J W Smith,et al. Substrate Hydrolysis by Matrix Metalloproteinase-9* , 2001, The Journal of Biological Chemistry.
[214] O. Volpert,et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. , 1996, The Journal of clinical investigation.
[215] Y. Chu,et al. Expression of axl in lung adenocarcinoma and correlation with tumor progression. , 2005, Neoplasia.
[216] A. Dufour,et al. Small Molecule Anti-Cancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9 ( MMP-9 ) , 2011 .
[217] John Kurhanewicz,et al. Activation of Pro-gelatinase B by Endometase/Matrilysin-2 Promotes Invasion of Human Prostate Cancer Cells* , 2003, The Journal of Biological Chemistry.
[218] P. E. Van den Steen,et al. Gelatinase B: a tuner and amplifier of immune functions. , 2001, Trends in immunology.
[219] Ping-Chang Yang,et al. Cancer-derived matrix metalloproteinase-9 contributes to tumor tolerance , 2011, Journal of Cancer Research and Clinical Oncology.
[220] D. Monard,et al. A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins , 1986, Cell.
[221] Ming Yan,et al. Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17) , 2012, Journal of enzyme inhibition and medicinal chemistry.
[222] Y. St-Pierre,et al. Epigenetic regulation of mmp-9 gene expression , 2012, Cellular and Molecular Life Sciences.
[223] V. Grange‐Messent,et al. Matrix metalloproteinases MMP2 and MMP9 are upregulated by noradrenaline in the mouse neuroendocrine hypothalamus , 2008, The European journal of neuroscience.
[224] H. Birkedal‐Hansen,et al. Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. , 1991, The Journal of biological chemistry.
[225] H. Zoghbi,et al. ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization. , 2011, Developmental cell.
[226] Z. Hall. Cancer , 1906, The Hospital.
[227] R. Kauppinen,et al. Minocycline Protects against Permanent Cerebral Ischemia in Wild Type but Not in Matrix Metalloprotease-9-Deficient Mice , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[228] Vandana Iyer,et al. Alpha3beta1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expression. , 2005, Journal of cell science.
[229] Christopher M Overall,et al. Proteomics Discovery of Metalloproteinase Substrates in the Cellular Context by iTRAQ™ Labeling Reveals a Diverse MMP-2 Substrate Degradome*S , 2007, Molecular & Cellular Proteomics.
[230] S. Meroueh,et al. Molecular structures and dynamics of the stepwise activation mechanism of a matrix metalloproteinase zymogen: challenging the cysteine switch dogma. , 2007, Journal of the American Chemical Society.
[231] Xiaoping Xu,et al. Functional basis for the overlap in ligand interactions and substrate specificities of matrix metalloproteinases-9 and -2. , 2005, The Biochemical journal.
[232] A. Roberts,et al. Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta. , 2005, Journal of cell science.
[233] L. Coussens,et al. RECKing MMP function: implications for cancer development. , 2002, Trends in cell biology.
[234] R. Kiss,et al. Human monocyte-derived dendritic cells produce bioactive gelatinase B: inhibition by IFN-beta. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[235] R. Gutzmer,et al. Histamine upregulates keratinocyte MMP-9 production via the histamine H1 receptor. , 2008, The Journal of investigative dermatology.
[236] S. Piao,et al. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma , 2012, Journal of Cancer Research and Clinical Oncology.
[237] Sidney R. Cohen,et al. Direct Visualization of Protease Action on Collagen Triple Helical Structure , 2010, PloS one.
[238] J. Badimón,et al. The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP‐1 and MMP‐9 in human macrophages in vitro , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[239] M. Shibuya,et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. , 2002, Cancer cell.
[240] H. Makarenkova,et al. Matrix Metalloproteinase (MMP)-9 Induced by Wnt Signaling Increases the Proliferation and Migration of Embryonic Neural Stem Cells at Low O2 Levels* , 2011, The Journal of Biological Chemistry.
[241] F. Iavarone,et al. Enzymatic processing by MMP‐2 and MMP‐9 of wild‐type and mutated mouse β‐dystroglycan , 2012, IUBMB life.
[242] R. Kowluru,et al. Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9 , 2012, Expert opinion on investigational drugs.
[243] Chia-Yen Dai,et al. OxLDL up‐regulates microRNA‐29b, leading to epigenetic modifications of MMP‐2/MMP‐9 genes: a novel mechanism for cardiovascular diseases , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[244] Jie Zhang,et al. KISS-1 inhibits the proliferation and invasion of gastric carcinoma cells. , 2012, World journal of gastroenterology.
[245] C. Demur,et al. Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features , 2008, Cell cycle.
[246] P. Leung,et al. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9. , 2006, Cancer research.
[247] A. Krüger,et al. On the Pro-Metastatic Stress Response to Cancer Therapies: Evidence for a Positive Co-Operation between TIMP-1, HIF-1α, and miR-210 , 2012, Front. Pharmacol..
[248] P. Fong,et al. SERPIN Regulation of Factor XIa , 2000, The Journal of Biological Chemistry.
[249] G. Opdenakker,et al. Gelatinase B in vernal keratoconjunctivitis. , 2001, Archives of ophthalmology.
[250] T. Keck,et al. Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma , 2011, Angiogenesis.
[251] Ping Xu,et al. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. , 2002, The Journal of clinical endocrinology and metabolism.
[252] A. Dufour,et al. Role of Matrix Metalloproteinase-9 Dimers in Cell Migration , 2010, The Journal of Biological Chemistry.
[253] W. Wu,et al. Effects of adrenaline in human colon adenocarcinoma HT-29 cells. , 2011, Life sciences.
[254] S. Itohara,et al. Contribution of host MMP‐2 and MMP‐9 to promote tumor vascularization and invasion of malignant keratinocytes , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[255] Andries Zijlstra,et al. Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination. , 2005, Cancer research.
[256] L. Lim,et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.
[257] Thiennu H. Vu,et al. Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation , 2010, Disease Models & Mechanisms.
[258] S. Beers. Systemic Autoimmune Disease , 2001 .
[259] E. Mendis,et al. Carboxylated chitooligosaccharides (CCOS) inhibit MMP-9 expression in human fibrosarcoma cells via down-regulation of AP-1. , 2006, Biochimica et biophysica acta.
[260] N. Mukaida,et al. Absence of IFN-γ accelerates thrombus resolution through enhanced MMP-9 and VEGF expression in mice. , 2011, The Journal of clinical investigation.
[261] P. Gibson,et al. Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis , 2003, European Respiratory Journal.
[262] M. Terol,et al. MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration. , 2006, Blood.
[263] A. Faussat,et al. Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia , 2006, Leukemia.
[264] Benoit Paquette,et al. Activation of matrix metalloproteinase-2 and -9 by 2- and 4-hydroxyestradiol , 2003, The Journal of Steroid Biochemistry and Molecular Biology.
[265] J. Yagüe,et al. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. , 1999, Blood.
[266] D. Neal,et al. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion , 2003, Oncogene.
[267] C. Dogra,et al. TNF‐related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle‐wasting cytokine , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[268] A. Burgess,et al. Regulation of Transforming Growth Factor-β Signaling , 2001 .
[269] Huamin Wang,et al. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. , 2009, Pathology, research and practice.
[270] T. Betsuyaku,et al. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. , 1999, American journal of respiratory cell and molecular biology.
[271] Larine Nee,et al. TNF-α and IL-1β–mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells , 2004 .
[272] S. Lipton,et al. Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. , 2005, Investigative ophthalmology & visual science.
[273] J. Quigley,et al. Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. , 2011, The American journal of pathology.
[274] Yusuke Yamamoto,et al. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[275] I. D. de Esch,et al. Molecular pharmacology of the four histamine receptors. , 2010, Advances in experimental medicine and biology.
[276] John R. Ledford,et al. A TLR2 Agonist in German Cockroach Frass Activates MMP-9 Release and Is Protective against Allergic Inflammation in Mice1 , 2009, The Journal of Immunology.
[277] P. Elliott,et al. A protein deacetylase SIRT1 is a negative regulator of metalloproteinase‐9 , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[278] Christopher M Overall,et al. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. , 2006, Nature reviews. Cancer.
[279] B. Bauvois,et al. Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons , 2002, Leukemia.
[280] Z. Werb,et al. Developmental Biology: Vasculogenesis is a Wreck Without RECK , 2002, Current Biology.
[281] Jason L Johnson,et al. Matrix Metalloproteinase (MMP)-3 Activates MMP-9 Mediated Vascular Smooth Muscle Cell Migration and Neointima Formation in Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[282] B. Cauwe,et al. The Biochemical, Biological, and Pathological Kaleidoscope of Cell Surface Substrates Processed by Matrix Metalloproteinases , 2007, Critical reviews in biochemistry and molecular biology.
[283] S. Nagahiro,et al. Edaravone, a Free Radical Scavenger, Inhibits MMP-9–Related Brain Hemorrhage in Rats Treated With Tissue Plasminogen Activator , 2009, Stroke.
[284] P. Carmeliet,et al. Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. , 2005, The American journal of pathology.
[285] A. Ludolph,et al. MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS , 2010, Journal of the Neurological Sciences.
[286] A. Krüger,et al. Distinct Functionality of Tumor Cell–Derived Gelatinases during Formation of Liver Metastases , 2008, Molecular Cancer Research.
[287] X. Leleu,et al. Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor , 2004, Leukemia.
[288] Maya Ram,et al. Matrix Metalloproteinase-9 and Autoimmune Diseases , 2006, Journal of Clinical Immunology.
[289] P. Venge,et al. Lipocalins as biochemical markers of disease. , 2000, Biochimica et biophysica acta.
[290] L. Kaczmarek,et al. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain , 2004, FEBS letters.
[291] J. Hofsteenge,et al. Glial-derived neurite-promoting factor is a slow-binding inhibitor of trypsin, thrombin, and urokinase. , 1987, Archives of biochemistry and biophysics.
[292] R. Derynck,et al. Essential role of TGF-beta signaling in glucose-induced cell hypertrophy. , 2009, Developmental cell.
[293] Guy Riddihough,et al. Structure of collagen , 1998, Nature Structural Biology.
[294] G. Opdenakker,et al. In vivo activation of gelatinase B/MMP‐9 by trypsin in acute pancreatitis is a permissive factor in streptozotocin‐induced diabetes , 2004, The Journal of pathology.
[295] S. Leib,et al. Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway. , 2003, The Journal of infectious diseases.
[296] Q. Duh,et al. Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors. , 2011, Surgery.
[297] D. Armant,et al. Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9. , 2011, Reproduction.
[298] Y. Itoh,et al. Preferential Inactivation of Tissue Inhibitor of Metalloproteinases-1 That Is Bound to the Precursor of Matrix Metalloproteinase 9 (Progelatinase B) by Human Neutrophil Elastase (*) , 1995, The Journal of Biological Chemistry.
[299] T. Tamaya,et al. Coexpression of Gas6/Axl in Human Ovarian Cancers , 2004, Oncology.
[300] M. Kuo,et al. Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-κB signal transduction pathway , 2006, Oncogene.
[301] H. Larjava,et al. Differential expression of matrilysin‐1 (MMP‐7), 92 kD gelatinase (MMP‐9), and metalloelastase (MMP‐12) in oral verrucous and squamous cell cancer , 2004, The Journal of pathology.
[302] L. Arckens,et al. A proteomic approach for the analysis of instantly released wound and immune proteins in Drosophila melanogaster hemolymph. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[303] Larine Nee,et al. TNF-alpha and IL-1beta-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells. , 2004, Kidney international.
[304] Yunhee Lee,et al. Matrix Metalloproteinase Gelatinase B (MMP-9) Coordinates and Effects Epithelial Regeneration* , 2002, The Journal of Biological Chemistry.
[305] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[306] L. Pfeffer,et al. The Interferon-γ-induced GTPase, mGBP-2, Inhibits Tumor Necrosis Factor α (TNF-α) Induction of Matrix Metalloproteinase-9 (MMP-9) by Inhibiting NF-κB and Rac Protein* , 2011, The Journal of Biological Chemistry.
[307] F. Aoudjit,et al. Gelatinase B (MMP‐9) production and expression by stromal cells in the normal and adult thymus and experimental thymic lymphoma , 1997, International journal of cancer.
[308] M. Cuzner,et al. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system , 1999, Journal of Neuroimmunology.
[309] T. Hardingham,et al. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. , 1992, The Journal of biological chemistry.
[310] C. Egas,et al. Expression of genes encoding extracellular matrix macromolecules and metalloproteinases in avian tibial dyschondroplasia. , 2011, Journal of comparative pathology.
[311] N. Cirillo,et al. Metalloproteinase 9 is the outer executioner of desmoglein 3 in apoptotic keratinocytes. , 2007, Oral diseases.
[312] Toshihiro Tanaka,et al. A functional polymorphism in THBS2 that affects alternative splicing and MMP binding is associated with lumbar-disc herniation. , 2008, American journal of human genetics.
[313] L. Kotra,et al. Characterization of the Monomeric and Dimeric Forms of Latent and Active Matrix Metalloproteinase-9 , 2000, The Journal of Biological Chemistry.
[314] T. van der Poll,et al. Matrix Metalloproteinase-9 Deficiency Impairs Host Defense against Abdominal Sepsis1 , 2006, The Journal of Immunology.
[315] M. Terol,et al. Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain. , 2010, Cancer cell.
[316] Z. Werb,et al. The Serpin α1-Proteinase Inhibitor Is a Critical Substrate for Gelatinase B/MMP-9 In Vivo , 2000, Cell.
[317] U. Stenman,et al. Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy , 2008, Annals of medicine.
[318] Vincenza Dolo,et al. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. , 2002, The American journal of pathology.
[319] Robert J. Moore,et al. TNF-α regulates epithelial expression of MMP-9 and integrin αvβ6 during tumour promotion. A role for TNF-α in keratinocyte migration? , 2004, Oncogene.
[320] Y Ikawa,et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[321] G. Opdenakker,et al. Gastric gelatinase B/matrix metalloproteinase-9 is rapidly increased in Helicobacter felis-induced gastritis. , 2008, FEMS immunology and medical microbiology.
[322] D. Wulsin,et al. Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis. , 2009, Matrix biology : journal of the International Society for Matrix Biology.
[323] W. Koenig,et al. Antidiabetic PPAR&ggr;-Activator Rosiglitazone Reduces MMP-9 Serum Levels in Type 2 Diabetic Patients With Coronary Artery Disease , 2003 .
[324] J. Talmadge,et al. Use of Matrix Metalloproteinase (MMP)‐9 Knockout Mice Demonstrates that MMP‐9 Activity Is not Absolutely Required for G‐CSF or Flt‐3 Ligand‐Induced Hematopoietic Progenitor Cell Mobilization or Engraftment , 2003, Stem cells.
[325] D. Albert,et al. Expression of the Receptor Tyrosine Kinase Axl Promotes Ocular Melanoma Cell Survival , 2004, Cancer Research.
[326] L. Kotra,et al. N-Glycosylation pattern of the zymogenic form of human matrix metalloproteinase-9. , 2002, Bioorganic chemistry.
[327] D. Chakravarty,et al. Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[328] M. Terol,et al. Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells. , 2008, Blood.
[329] P. E. Van den Steen,et al. Gelatinase B/matrix metalloproteinase‐9 provokes cataract by cleaving lens βB1 crystallin , 2005 .
[330] P. Bornstein,et al. Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9 , 2009, Journal of leukocyte biology.
[331] H. Hsieh,et al. IL‐1β induces MMP‐9 expression via a Ca2+‐dependent CaMKII/JNK/c‐JUN cascade in rat brain astrocytes , 2009, Glia.
[332] A. Burgess,et al. Regulation of transforming growth factor-beta signaling. , 2001, Molecular cell biology research communications : MCBRC.
[333] Jakub Wlodarczyk,et al. Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology , 2011, Journal of Cell Science.
[334] G. Opdenakker,et al. Zymography methods for visualizing hydrolytic enzymes , 2013, Nature Methods.
[335] R. Huber,et al. Structural basis of the adaptive molecular recognition by MMP9. , 2002, Journal of molecular biology.
[336] C. Gondi,et al. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis , 2004, Oncogene.
[337] B. Cauwe,et al. Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune disease. , 2011, Journal of autoimmunity.
[338] S. Lorenzl,et al. The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice. , 2006, Experimental neurology.
[339] J. Shirani,et al. Matrix metalloproteinase expression in nonrheumatic aortic stenosis. , 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[340] G. Opdenakker,et al. Interphotoreceptor retinoid-binding protein as biomarker in systemic autoimmunity with eye inflictions , 2008, Journal of cellular and molecular medicine.
[341] F. Hamada,et al. ATP Potentiates Interleukin-1β-induced MMP-9 Expression in Mesangial Cells via Recruitment of the ELAV Protein HuR* , 2003, Journal of Biological Chemistry.
[342] E. Lo,et al. MMP-9–Positive Neutrophil Infiltration Is Associated to Blood–Brain Barrier Breakdown and Basal Lamina Type IV Collagen Degradation During Hemorrhagic Transformation After Human Ischemic Stroke , 2008, Stroke.
[343] Jing Ping Zhang,et al. MicroRNA‐29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression , 2011, Hepatology.
[344] B. Aggarwal,et al. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-κB activation through inhibition of IκBα kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1 , 2003 .
[345] T. Ugarova,et al. Differential Induction of Gelatinase B (MMP-9) and Gelatinase A (MMP-2) in T Lymphocytes upon α4β1-Mediated Adhesion to VCAM-1 and the CS-1 Peptide of Fibronectin☆ , 2000 .
[346] A. Roberts,et al. Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-β , 2005, Journal of Cell Science.
[347] R. Vandenbroucke,et al. Matrix metalloproteinases as drug targets in ischemia/reperfusion injury. , 2011, Drug discovery today.
[348] H. Osada,et al. RECK negatively regulates matrix metalloproteinase-9 transcription. , 2009, Cancer research.
[349] J Günter Grossmann,et al. Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B. , 2007, Structure.
[350] P. E. Van den Steen,et al. Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins , 2007, Journal of leukocyte biology.
[351] J. Folkman,et al. The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.
[352] Z. Werb,et al. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. , 2005, The Journal of clinical investigation.
[353] S. Itohara,et al. Different Roles for Matrix Metalloproteinase‐2 and Matrix Metalloproteinase‐9 in the Pathogenesis of Cardiac Allograft Rejection , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[354] P. Libby,et al. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. , 1998, Journal of immunology.
[355] Y. Miyamoto,et al. Activation of Matrix Metalloproteinases by Peroxynitrite-induced Protein S-Glutathiolation via Disulfide S-Oxide Formation* , 2001, The Journal of Biological Chemistry.
[356] W. Yarbrough,et al. LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB. , 2007, Cancer cell.
[357] W. Koenig,et al. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[358] G. Ahn,et al. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. , 2008, Cancer cell.
[359] M. Slepian,et al. Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation. , 2011, Pharmacological research.
[360] S. Tyagi,et al. Tumor Necrosis Factor-related Weak Inducer of Apoptosis Augments Matrix Metalloproteinase 9 (MMP-9) Production in Skeletal Muscle through the Activation of Nuclear Factor-κB-inducing Kinase and p38 Mitogen-activated Protein Kinase , 2009, Journal of Biological Chemistry.
[361] E. Roets,et al. The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors. , 1996, Biochemical pharmacology.
[362] R. Panush. Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential , 2012 .
[363] R. Muschel,et al. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. , 1996, Cancer research.
[364] P. E. Van den Steen,et al. Neutrophil MMP-9 Proenzyme, Unencumbered by TIMP-1, Undergoes Efficient Activation in Vivo and Catalytically Induces Angiogenesis via a Basic Fibroblast Growth Factor (FGF-2)/FGFR-2 Pathway* , 2009, The Journal of Biological Chemistry.
[365] Z. Werb,et al. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. , 1977, The New England journal of medicine.
[366] T. Jay,et al. TIMP-1 Abolishes MMP-9-Dependent Long-lasting Long-term Potentiation in the Prefrontal Cortex , 2007, Biological Psychiatry.
[367] W. Zhong,et al. CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate Cancer , 2008, Oncology.
[368] P. E. Van den Steen,et al. Increased gelatinase B/matrix metalloproteinase 9 (MMP-9) activity in a murine model of acute coxsackievirus B4-induced pancreatitis. , 2008, Virology.
[369] B. Baxter,et al. MMP-9 Microsatellite Polymorphism and Susceptibility to Carotid Arteries Atherosclerosis , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[370] B. Heissig,et al. Role of neutrophil-derived matrix metalloproteinase-9 in tissue regeneration. , 2010, Histology and histopathology.
[371] S. Itohara,et al. Inhibition of obliterative airway disease development in murine tracheal allografts by matrix metalloproteinase-9 deficiency. , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[372] Claudia Wickenhauser,et al. Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression. , 2011, Cancer research.
[373] R. Powers,et al. The application of x-ray, NMR, and molecular modeling in the design of MMP inhibitors. , 2004, Current topics in medicinal chemistry.
[374] B. Chung,et al. Expression of the proto-oncogene Axl in renal cell carcinoma. , 2003, DNA and cell biology.
[375] Zhiwei Wang,et al. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. , 2007, Cancer research.
[376] Elliot L. Elson,et al. Interstitial Collagenase Is a Brownian Ratchet Driven by Proteolysis of Collagen , 2004, Science.
[377] Vandana Iyer,et al. Integrin alpha3beta1 potentiates TGFbeta-mediated induction of MMP-9 in immortalized keratinocytes. , 2008, The Journal of investigative dermatology.
[378] G. Opdenakker,et al. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. , 1993, Biochemical and biophysical research communications.
[379] Jialiang Hu,et al. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases , 2007, Nature Reviews Drug Discovery.
[380] C. Monneret,et al. Histone deacetylase inhibitors. , 2005, European journal of medicinal chemistry.
[381] Liduan Zheng,et al. microRNA-9 Targets Matrix Metalloproteinase 14 to Inhibit Invasion, Metastasis, and Angiogenesis of Neuroblastoma Cells , 2012, Molecular Cancer Therapeutics.
[382] Amitava Das,et al. Disruption of an SP2/KLF6 Repression Complex by SHP Is Required for Farnesoid X Receptor-induced Endothelial Cell Migration* , 2006, Journal of Biological Chemistry.
[383] K. Tai,et al. Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1 , 2008, Oncogene.
[384] William Arbuthnot Sir Lane,et al. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.
[385] N. Hynes,et al. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression. , 2009, Cancer research.
[386] G. Ferry,et al. Activation of MMP‐9 by neutrophil elastase in an in vivo model of acute lung injury , 1997, FEBS letters.
[387] Gillian Murphy,et al. Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.
[388] Christopher M Overall,et al. Protease yoga: extreme flexibility of a matrix metalloproteinase. , 2007, Structure.
[389] A. Krüger,et al. Avoiding spam in the proteolytic internet: future strategies for anti-metastatic MMP inhibition. , 2010, Biochimica et biophysica acta.
[390] L. Kong,et al. EMMPRIN contributes to the in vitro invasion of human salivary adenoid cystic carcinoma cells , 2011, Oncology reports.
[391] E. Bröcker,et al. Granulocyte‐derived elastase and gelatinase B are required for dermal–epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid , 2004, The Journal of pathology.
[392] G. Opdenakker,et al. Gelatinase B deficiency impairs reproduction. , 2000, The Journal of clinical investigation.
[393] R. Harrison,et al. Classically Activated Macrophages Use Stable Microtubules for Matrix Metalloproteinase-9 (MMP-9) Secretion* , 2012, The Journal of Biological Chemistry.
[394] G. Opdenakker,et al. Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates. , 2009, Integrative biology : quantitative biosciences from nano to macro.
[395] M A Moses,et al. Increased incidence of matrix metalloproteinases in urine of cancer patients. , 1998, Cancer research.
[396] S. Rafii,et al. Matrix metalloproteinase-9 regulates TNF-α and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis , 2007, Experimental Neurology.
[397] Wei‐Ting Lee,et al. Melatonin inhibits postischemic matrix metalloproteinase‐9 (MMP‐9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia , 2010, Journal of pineal research.
[398] B. Marmer,et al. Substrate Binding of Gelatinase B Induces Its Enzymatic Activity in the Presence of Intact Propeptide* , 2002, The Journal of Biological Chemistry.
[399] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[400] T. Standiford,et al. Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. , 2006, Human pathology.
[401] I. Papassotiriou,et al. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease , 2009, BMC Cancer.
[402] J. Chung,et al. Reactive oxygen species produced by NADPH oxidase, xanthine oxidase, and mitochondrial electron transport system mediate heat shock-induced MMP-1 and MMP-9 expression. , 2008, Free radical biology & medicine.
[403] Fan Zhang,et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes , 2006, Nature Medicine.
[404] Vandana Iyer,et al. Integrin α3β1 potentiates TGFβ-mediated induction of MMP-9 in immortalized keratinocytes , 2008 .
[405] R. Willemze,et al. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[406] Amitava Das,et al. FXR Promotes Endothelial Cell Motility Through Coordinated Regulation of FAK and MMP-9 , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[407] B. Beutler,et al. The Rab27a Effectors JFC1/Slp1 and Munc13‐4 Regulate Exocytosis of Neutrophil Granules , 2008, Traffic.
[408] D. Chitwood,et al. Small RNAs are on the move , 2010, Nature.
[409] J. Adair,et al. Measurement of Gelatinase B (MMP-9) in the Cerebrospinal Fluid of Patients With Vascular Dementia and Alzheimer Disease , 2004, Stroke.
[410] G. Opdenakker,et al. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. , 1991, European journal of biochemistry.
[411] C. Gargioli,et al. PlGF–MMP-9–expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle , 2008, Nature Medicine.
[412] L. Kaczmarek,et al. β-Dystroglycan as a Target for MMP-9, in Response to Enhanced Neuronal Activity* , 2007, Journal of Biological Chemistry.
[413] K. Pumiglia,et al. An immortalization-dependent switch in integrin function up-regulates MMP-9 to enhance tumor cell invasion. , 2008, Cancer research.
[414] Y. Hsu,et al. TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis* , 1997, The Journal of Biological Chemistry.
[415] A. Dufour,et al. Role of the hemopexin domain of matrix metalloproteinases in cell migration , 2008, Journal of cellular physiology.
[416] R. Dwek,et al. The Hemopexin and O-Glycosylated Domains Tune Gelatinase B/MMP-9 Bioavailability via Inhibition and Binding to Cargo Receptors* , 2006, Journal of Biological Chemistry.
[417] S. Lorenzl,et al. The matrix metalloproteinases inhibitor Ro 26-2853 extends survival in transgenic ALS mice , 2006, Experimental Neurology.
[418] N. Borregaard,et al. Neutrophils, from marrow to microbes. , 2010, Immunity.
[419] F. Costa,et al. Non-coding RNAs: lost in translation? , 2007, Gene.
[420] T. Salo,et al. Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition. , 2006, International journal of cardiology.
[421] Y. Wada,et al. Role of Neutrophils in Matrix Metalloproteinase Activity in the Preimplantation Mouse Uterus1 , 2005, Biology of reproduction.
[422] W. Lau,et al. Subnanometre-resolution structure of the intact Thermus thermophilus H+-driven ATP synthase , 2011, Nature.
[423] A. von Deimling,et al. Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase‐2 and MMP‐9 , 2006, Cancer.
[424] C. Chi,et al. Clinical significance of AXL kinase family in gastric cancer. , 2002, Anticancer research.
[425] S. Vandenberg,et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. , 2008, Cancer cell.
[426] J. R. Mitchell,et al. The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study , 2007, Multiple sclerosis.
[427] H. Matsumoto,et al. The Membrane-Anchored Matrix Metalloproteinase (MMP) Regulator RECK in Combination with MMP-9 Serves as an Informative Prognostic Indicator for Colorectal Cancer , 2004, Clinical Cancer Research.
[428] A. Knox,et al. Autocrine production of matrix metalloproteinase-2 is required for human airway smooth muscle proliferation. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[429] Cameron Torcassi,et al. Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease , 2010, Neuron.
[430] E. Arama,et al. Can’t live without them, can live with them: roles of caspases during vital cellular processes , 2009, Apoptosis.
[431] S. Chakraborti,et al. Regulation of matrix metalloproteinases: An overview , 2003, Molecular and Cellular Biochemistry.
[432] Hiroyuki Yamamoto,et al. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma. , 2004, Carcinogenesis.
[433] Xiao-Jing Wang. Role of TGFβ signaling in skin carcinogenesis , 2001 .
[434] D. Edwards,et al. The regulation of matrix metalloproteinases and their inhibitors. , 2008, The international journal of biochemistry & cell biology.
[435] B. Nielsen,et al. 92 kDa type IV collagenase (MMP‐9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer , 1996, International journal of cancer.
[436] H. Lijnen,et al. Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice. , 1998, Blood.
[437] H. Iwasaki,et al. Emmprin (basigin/CD147): Matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression , 2006, Pathology international.
[438] G. Murphy,et al. Gelatinases A and B. , 2002, Methods in enzymology.
[439] J. Bousquet,et al. In vitro effects of flunisolide on MMP‐9, TIMP‐1, fibronectin, TGF‐β1 release and apoptosis in sputum cells freshly isolated from mild to moderate asthmatics , 2004, Allergy.
[440] L. Jinhui,et al. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication , 2009 .
[441] Xinyu Zhao,et al. Endogenous Matrix Metalloproteinase (MMP)‐3 and MMP‐9 Promote the Differentiation and Migration of Adult Neural Progenitor Cells in Response to Chemokines , 2008, Stem cells.
[442] Gerald Maurer,et al. Catecholamines potentiate LPS‐induced expression of MMP‐1 and MMP‐9 in human monocytes and in the human monocytic cell line U937: possible implications for peri‐ operative plaque instability , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[443] H. Hsieh,et al. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor‐kappa B in interleukin‐1β‐induced matrix metalloproteinase‐9 expression in rat brain astrocytes , 2004, Journal of neurochemistry.
[444] G. Opdenakker,et al. Expression of gelatinase B in trachomatous conjunctivitis , 2000, The British journal of ophthalmology.
[445] P. E. Van den Steen,et al. Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B. , 2004, Biochemistry.
[446] I. Sagi,et al. Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition? , 2010, Biochimica et biophysica acta.
[447] T. Sorsa,et al. Is the excessive inhibition of matrix metalloproteinases (MMPs) by potent synthetic MMP inhibitors (MMPIs) desirable in periodontitis and other inflammatory diseases? That is: 'Leaky' MMPIs vs excessively efficient drugs. , 2005, Oral diseases.
[448] G. Opdenakker,et al. Probing cytokines, chemokines and matrix metalloproteinases towards better immunotherapies of multiple sclerosis. , 2011, Cytokine & growth factor reviews.
[449] R. Hynes,et al. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. , 2003, Cancer cell.
[450] N. Mukaida,et al. Absence of IFN‐gamma accelerates thrombus resolution through enhanced MMP‐9 and VEGF expression , 2009 .
[451] C. Power,et al. For Personal Use. Only Reproduce with Permission from Elsevier Ltd Minocycline and Neurological Diseases Minocycline in Animal Models the Promise of Minocycline in Neurology , 2022 .
[452] A. Colombatti,et al. Hyaluronan–CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9 , 2002, The Journal of cell biology.
[453] M. Chopp,et al. MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3. , 2013, Cancer letters.
[454] J. Lefaucheur,et al. MMP-9 correlates with electrophysiologic abnormalities in Guillain–Barré syndrome , 2002, Neurology.
[455] R. Gilman,et al. High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation , 2009, European Respiratory Journal.
[456] R. Dwek,et al. Matrix remodelling enzymes, the protease cascade and glycosylation. , 2001, Biochimica et biophysica acta.
[457] G. Opdenakker,et al. The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage. , 2006, Experimental eye research.
[458] Alan W. Stitt. AGEs and diabetic retinopathy. , 2010, Investigative ophthalmology & visual science.
[459] Carine Munaut,et al. MMP‐2 and MMP‐9 synergize in promoting choroidal neovascularization , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[460] M. Gujrati,et al. MMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16(INK4a) and mitogen-activated protein kinase pathway. , 2007, Cancer research.
[461] R. Hynes,et al. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. , 2003, Cancer cell.
[462] R. Dwek,et al. Concepts and principles of O-linked glycosylation. , 1998, Critical reviews in biochemistry and molecular biology.
[463] E. Hurt-Camejo,et al. Matrix management: assigning different roles for MMP-2 and MMP-9 in vascular remodeling. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[464] L. Languino,et al. Protein kinase D1 inhibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase-9 secretion in prostate cancer. , 2010, Cancer research.
[465] J. Clancy,et al. Human Neutrophil Elastase-Mediated Cleavage Sites of MMP-9 and TIMP-1: Implications to Cystic Fibrosis Proteolytic Dysfunction , 2010, Molecular medicine.
[466] A. Mine,et al. Inhibition of Enzymatic Degradation of Adhesive-Dentin Interfaces , 2009, Journal of dental research.
[467] Gillian Murphy,et al. Metalloproteinase inhibitors: biological actions and therapeutic opportunities , 2002, Journal of Cell Science.
[468] H. Sengeløv,et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. , 1993, The Journal of biological chemistry.
[469] V. Dolo,et al. Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. , 1994, Journal of submicroscopic cytology and pathology.
[470] S. Fukuda,et al. Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRObeta/CXCL2 and GRObetaT/CXCL2delta4. , 2004, Blood.
[471] A. Traboulsee,et al. Glatiramer acetate in combination with minocycline in patients with relapsing—remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial , 2009, Multiple sclerosis.
[472] R. Dwek,et al. O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme. , 2000, Biochemistry.
[473] G. Opdenakker,et al. Natural human monocyte gelatinase and its inhibitor , 1991, FEBS letters.
[474] Voon Wee Yong,et al. Matrix metalloproteinases and diseases of the CNS , 1998, Trends in Neurosciences.
[475] D. Huylebroeck,et al. Few Smad proteins and many Smad-interacting proteins yield multiple functions and action modes in TGFβ/BMP signaling in vivo. , 2011, Cytokine & growth factor reviews.
[476] R. Willemze,et al. Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization. , 2004, Blood.
[477] M. Quail,et al. Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium , 2010, Science.
[478] P. Eriksson,et al. Infection with Human Cytomegalovirus Alters the MMP-9/TIMP-1 Balance in Human Macrophages , 2008, Journal of Virology.
[479] A. Salama,et al. Matrix metalloproteinase‐9 (gelatinase B) is elevated during mobilization of peripheral blood progenitor cells by G–CSF , 2002, Transfusion.
[480] J. H. Lee,et al. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. , 1997, Cancer research.
[481] Neil D. Rawlings,et al. MEROPS: the peptidase database , 2009, Nucleic Acids Res..
[482] J. Clancy,et al. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[483] Z. Werb,et al. Proteomic Identification of In Vivo Substrates for Matrix Metalloproteinases 2 and 9 Reveals a Mechanism for Resolution of Inflammation1 , 2006, The Journal of Immunology.
[484] V. Shubayev,et al. MMP‐9 controls Schwann cell proliferation and phenotypic remodeling via IGF‐1 and ErbB receptor‐mediated activation of MEK/ERK pathway , 2009, Glia.
[485] K. Bötzel,et al. Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation , 2012, Experimental Neurology.
[486] M. Swellam,et al. Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine. , 2007, European urology.
[487] G. Mills,et al. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression , 2011, Oncogene.
[488] S. Arii,et al. RECK gene expression in hepatocellular carcinoma: Correlation with invasion‐related clinicopathological factors and its clinical significance , 2001, Hepatology.
[489] G. Opdenakker,et al. Cytokine-regulated proteases in autoimmune diseases. , 1994, Immunology today.
[490] M. Coletta,et al. pH- and temperature-dependence of functional modulation in metalloproteinases. A comparison between neutrophil collagenase and gelatinases A and B. , 2000, Biophysical journal.
[491] P. Allavena,et al. The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance , 2008, Immunological reviews.
[492] K. Kohyama,et al. Matrix Metalloproteinase (MMP)-9, but Not MMP-2, Is Involved in the Development and Progression of C Protein-Induced Myocarditis and Subsequent Dilated Cardiomyopathy1 , 2009, The Journal of Immunology.
[493] Masahiro Inoue,et al. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. , 2004, The Journal of clinical investigation.
[494] Yi Tang,et al. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. , 2004, Molecular cancer research : MCR.
[495] S. Shapiro,et al. Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophils. , 2003, American journal of respiratory cell and molecular biology.
[496] M. Terol,et al. A 17-residue Sequence from the Matrix Metalloproteinase-9 (MMP-9) Hemopexin Domain Binds α4β1 Integrin and Inhibits MMP-9-induced Functions in Chronic Lymphocytic Leukemia B Cells* , 2012, The Journal of Biological Chemistry.
[497] C. Gondi,et al. Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro , 2002, Oncogene.
[498] Xuhui Liu,et al. Role of gelatinases in disuse‐induced skeletal muscle atrophy , 2010, Muscle & nerve.
[499] R. Muschel,et al. Novel MMP-9 Substrates in Cancer Cells Revealed by a Label-free Quantitative Proteomics Approach*S , 2008, Molecular & Cellular Proteomics.
[500] C. Henkel,et al. MMP-9-hemopexin domain hampers adhesion and migration of colorectal cancer cells. , 2007, International journal of oncology.
[501] P. E. Van den Steen,et al. Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections. , 2012, Pharmacology & therapeutics.
[502] T. Ugarova,et al. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin. , 2000, Experimental cell research.
[503] G. Opdenakker,et al. Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice , 2007, Leukemia.
[504] M. Baiocchi,et al. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. , 2002, Development.
[505] Jakub Wlodarczyk,et al. MMP9: a novel function in synaptic plasticity. , 2012, The international journal of biochemistry & cell biology.
[506] Kyung-Hee Lee,et al. Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer , 2010, Molecular and Cellular Biochemistry.
[507] A. Churg,et al. Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs , 2007, Thorax.
[508] V. Yong,et al. Metalloproteinases: Mediators of Pathology and Regeneration in the CNS , 2005, Nature Reviews Neuroscience.
[509] T. Turpeenniemi‐Hujanen,et al. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. , 2005, Biochimie.
[510] Gabriele Bergers,et al. MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.
[511] William C. Parks,et al. Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.
[512] G. Butler,et al. Human Tissue Inhibitor of Metalloproteinases 3 Interacts with Both the N- and C-terminal Domains of Gelatinases A and B , 1999, The Journal of Biological Chemistry.
[513] B. Fingleton,et al. Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. , 2008, Cancer research.
[514] R. Fridman,et al. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). , 1995, Cancer research.
[515] À. Rovira,et al. A Matrix Metalloproteinase Protein Array Reveals a Strong Relation Between MMP-9 and MMP-13 With Diffusion-Weighted Image Lesion Increase in Human Stroke , 2005, Stroke.
[516] P. Leung,et al. Dose-dependent effects of gonadotropin releasing hormone on matrix metalloproteinase (MMP)-2, and MMP-9 and tissue specific inhibitor of metalloproteinases-1 messenger ribonucleic acid levels in human decidual Stromal cells in vitro. , 2003, The Journal of clinical endocrinology and metabolism.
[517] K. Preissner,et al. Inhibition of Gelatinase B (Matrix Metalloprotease-9) Activity Reduces Cellular Inflammation and Restores Function of Transplanted Pancreatic Islets , 2012, Diabetes.
[518] P. Dimroth,et al. Unique rotary ATP synthase and its biological diversity. , 2008, Annual review of biophysics.
[519] Z. Werb,et al. Matrix remodeling during endochondral ossification. , 2004, Trends in cell biology.
[520] M. Wittmann,et al. Modulation of keratinocyte-derived MMP-9 by IL-13: a possible role for the pathogenesis of epidermal inflammation. , 2008, The Journal of investigative dermatology.
[521] Pauline M. Rudd,et al. Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9) , 2002, Critical reviews in biochemistry and molecular biology.
[522] Jian Li,et al. Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9. , 2011, Cancer research.
[523] G. Brewer,et al. The regulation of mRNA stability in mammalian cells: 2.0. , 2012, Gene.
[524] H. Emonard,et al. Involvement of Fibronectin Type II Repeats in the Efficient Inhibition of Gelatinases A and B by Long-chain Unsaturated Fatty Acids* , 2001, The Journal of Biological Chemistry.
[525] R. Nair,et al. Expression Cloning Identifies Transgelin (SM22) as a Novel Repressor of 92-kDa Type IV Collagenase (MMP-9) Expression* , 2006, Journal of Biological Chemistry.
[526] Z. Werb,et al. MMP9 regulates the cellular response to inflammation after skeletal injury. , 2013, Bone.
[527] R. Weichselbaum,et al. Inhibition of spontaneous metastases formation by amifostine , 2002, International journal of cancer.
[528] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[529] Yasmin,et al. Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[530] P. Span,et al. Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer. , 2006, Cancer letters.
[531] N. Turner,et al. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. , 2002, Journal of vascular surgery.
[532] J. Chauvin,et al. Differential vesicular distribution and trafficking of MMP‐2, MMP‐9, and their inhibitors in astrocytes , 2009, Glia.
[533] G. Poiana,et al. Acetylcholine induces neurite outgrowth and modulates matrix metalloproteinase 2 and 9. , 2007, Biochemical and biophysical research communications.
[534] M. Fini,et al. Deficiency in Matrix Metalloproteinase Gelatinase B (MMP-9) Protects against Retinal Ganglion Cell Death after Optic Nerve Ligation* , 2002, The Journal of Biological Chemistry.
[535] A. Mantovani,et al. Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[536] S. Shapiro,et al. Human 92- and 72-kilodalton type IV collagenases are elastases. , 1991, The Journal of biological chemistry.
[537] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[538] T. Jiang,et al. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme , 2011, Brain Research.
[539] C. Moore,et al. An alternate perspective on the roles of TIMPs and MMPs in pathology. , 2012, The American journal of pathology.
[540] N. Turner,et al. The FASEB Journal express article 10.1096/fj.04-2852fje. Published online February 23, 2005. ©2005 FASEB , 2022 .
[541] P. E. Van den Steen,et al. Inhibition of lethal endotoxin shock with an L-pyridylalanine containing metalloproteinase inhibitor selected by high-throughput screening of a new peptide library. , 2006, Combinatorial chemistry & high throughput screening.
[542] The novel function of advanced glycation end products in regulation of MMP-9 production. , 2010, The Journal of surgical research.
[543] S. Rafii,et al. Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.
[544] C. Janson,et al. Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase. , 2002, Acta crystallographica. Section D, Biological crystallography.
[545] W. Yarbrough,et al. LZAP, a Putative Tumor Suppressor, Selectively Inhibits NF-κB , 2007 .
[546] 石川 聡,et al. Matrix Metalloproteinase , 1997, Definitions.
[547] Robert J. Moore,et al. TNF-alpha regulates epithelial expression of MMP-9 and integrin alphavbeta6 during tumour promotion. A role for TNF-alpha in keratinocyte migration? , 2004, Oncogene.
[548] G. Bertenshaw,et al. Meprin proteolytic complexes at the cell surface and in extracellular spaces. , 2003, Biochemical Society symposium.
[549] Y. St-Pierre,et al. EGR-1 activation by EGF inhibits MMP-9 expression and lymphoma growth. , 2010, Blood.
[550] J. Clancy,et al. Early Elevation of Matrix Metalloproteinase-8 and -9 in Pediatric ARDS Is Associated with an Increased Risk of Prolonged Mechanical Ventilation , 2011, PloS one.
[551] V. Lagente,et al. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients , 2003, Critical care medicine.
[552] E. Cacci,et al. Neural stem cells at the crossroads: MMPs may tell the way. , 2009, The International journal of developmental biology.
[553] Liu Wei,et al. IL-17 Stimulates Migration of Carotid Artery Vascular Smooth Muscle Cells in an MMP-9 Dependent Manner via p38 MAPK and ERK1/2-Dependent NF-κB and AP-1 Activation , 2009, Cellular and Molecular Neurobiology.
[554] S. Chow,et al. Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. , 2003, Cancer research.
[555] H. Tschesche,et al. A 25 kDa α2‐microglobulin‐related protein is a component of the 125 kDa form of human gelatinase , 1992, FEBS letters.
[556] W. Hait,et al. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. , 2003, Molecular cancer research : MCR.
[557] G. Opdenakker,et al. Inflammatory rather than infectious insults play a role in exocrine tissue damage in a mouse model for coxsackievirus B4‐induced pancreatitis , 2009, The Journal of pathology.
[558] B. Berk,et al. The Gas6/Axl system: a novel regulator of vascular cell function. , 1999, Trends in cardiovascular medicine.
[559] R. Tuma,et al. Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression. , 2012, Blood.
[560] R. Meacham,et al. p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity. , 2010, Cancer research.
[561] M. Fini,et al. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. , 2005, The American journal of pathology.
[562] G. Opdenakker,et al. Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate. , 1990, Biochimica et biophysica acta.
[563] Xiaoying Wang,et al. Matrix metalloprotease regulation of neuropathic pain. , 2009, Trends in pharmacological sciences.
[564] Inge Nelissen,et al. Gelatinase B functions as regulator and effector in leukocyte biology , 2001, Journal of leukocyte biology.
[565] A. Pandiella,et al. Role of metalloproteinases MMP‐9 and MT1‐MMP in CXCL12‐promoted myeloma cell invasion across basement membranes , 2006, The Journal of pathology.
[566] I. Sancho-Martinez,et al. CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. , 2010, Immunity.
[567] A. E. Erson-Bensan,et al. Matrix metalloprotease 16 expression is downregulated by microRNA‐146a in spontaneously differentiating Caco‐2 cells , 2012, Development, growth & differentiation.
[568] V. Dolo,et al. Urokinase Plasminogen Activator and Gelatinases Are Associated with Membrane Vesicles Shed by Human HT1080 Fibrosarcoma Cells* , 1997, The Journal of Biological Chemistry.